Michael Untch
0000-0002-1233-1267
Publication & Citation Trends
Most Cited Works
Publications
1,373 total
Abstract RF2-01: Prognostic Markers in Residual Tumors after neoadjuvant chemotherapy (NACT) for Early Triple-negative Breast Cancer (TNBC) - a Pooled Analysis from nine Neoadjuvant GBG/AGO-B Trials
Cited by 0
Semantic Scholar
Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
Cited by 1
Semantic Scholar
ABC8 Consensus: Assessment by a German Group of Experts
Cited by 0
Semantic Scholar
Abstract RF3-02: Gene Expression-based Subtyping of Early Triple-Negative Breast Cancer (TNBC) for Prediction of Response to Neoadjuvant Immune-chemotherapy in the NSABP B-59/GBG-96-GeparDouze Trial
Cited by 0
Semantic Scholar
Abstract RF2-02: Pooled analysis of the BrighTNess, CALGB 40603 (Alliance), and GeparSixto clinical trials identifies the impact of neoadjuvant carboplatin on pCR and survival in early-stage triple-negative breast cancer
Cited by 0
Semantic Scholar
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer
Cited by 0
Semantic Scholar
Correction: Treatment of Patients with Early Breast Cancer
Cited by 0
Semantic Scholar
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.
Cited by 0
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(680)
HER2/EGFR in Cancer Research
(459)
Cancer Treatment and Pharmacology
(350)
Advanced Breast Cancer Therapies
(313)
Cancer Genomics and Diagnostics
(152)
Frequent Co-Authors
Affiliations
Supélec
Goethe University Frankfurt
University of Southern California
Roche (Switzerland)
Uppsala University